167.74
price down icon9.23%   -17.06
pre-market  プレマーケット:  170.00   2.26   +1.35%
loading
前日終値:
$184.80
開ける:
$178.65
24時間の取引高:
1.24M
Relative Volume:
1.27
時価総額:
$8.28B
収益:
$4.02B
当期純損益:
$-142.16M
株価収益率:
-56.74
EPS:
-2.9563
ネットキャッシュフロー:
$518.49M
1週間 パフォーマンス:
-5.20%
1か月 パフォーマンス:
+6.16%
6か月 パフォーマンス:
-12.16%
1年 パフォーマンス:
+53.89%
1日の値動き範囲:
Value
$165.55
$180.85
1週間の範囲:
Value
$165.55
$190.14
52週間の値動き範囲:
Value
$108.10
$228.88

Charles River Laboratories International Inc Stock (CRL) Company Profile

Name
名前
Charles River Laboratories International Inc
Name
セクター
Healthcare (1111)
Name
電話
781-222-6000
Name
住所
251 BALLARDVALE ST, WILMINGTON, MA
Name
職員
19,700
Name
Twitter
@criverlabs
Name
次回の収益日
2026-05-07
Name
最新のSEC提出書
Name
CRL's Discussions on Twitter

Compare CRL vs TMO, DHR, IDXX, A, WAT

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
CRL icon
CRL
Charles River Laboratories International Inc
167.74 9.03B 4.02B -142.16M 518.49M -2.9563
TMO icon
TMO
Thermo Fisher Scientific Inc
466.70 194.94B 45.20B 6.88B 6.75B 18.19
DHR icon
DHR
Danaher Corp
178.57 137.69B 24.78B 3.68B 5.29B 5.1743
IDXX icon
IDXX
Idexx Laboratories Inc
560.93 45.19B 4.30B 1.06B 1.04B 13.08
A icon
A
Agilent Technologies Inc
114.42 34.50B 7.07B 1.29B 993.00M 4.5355
WAT icon
WAT
Waters Corp
311.20 32.91B 3.17B 642.63M 516.49M 10.77

Charles River Laboratories International Inc Stock (CRL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-14 開始されました RBC Capital Mkts Outperform
2025-12-15 アップグレード BofA Securities Neutral → Buy
2025-11-17 アップグレード Argus Hold → Buy
2025-11-06 アップグレード Robert W. Baird Neutral → Outperform
2025-10-06 アップグレード William Blair Mkt Perform → Outperform
2025-10-02 アップグレード Barclays Equal Weight → Overweight
2025-09-09 アップグレード Jefferies Hold → Buy
2025-07-09 アップグレード Citigroup Neutral → Buy
2025-05-23 アップグレード Redburn Atlantic Neutral → Buy
2025-05-14 アップグレード TD Cowen Hold → Buy
2025-05-08 アップグレード Evercore ISI In-line → Outperform
2025-03-21 ダウングレード Goldman Buy → Neutral
2025-03-04 アップグレード Citigroup Sell → Neutral
2025-03-03 アップグレード Redburn Atlantic Sell → Neutral
2025-01-22 ダウングレード William Blair Outperform → Mkt Perform
2025-01-17 ダウングレード UBS Buy → Neutral
2024-11-18 ダウングレード CLSA Hold → Underperform
2024-11-07 アップグレード CLSA Underperform → Hold
2024-10-23 開始されました CLSA Underperform
2024-10-14 開始されました Redburn Atlantic Sell
2024-10-07 ダウングレード Evercore ISI Outperform → In-line
2024-10-02 ダウングレード BofA Securities Buy → Neutral
2024-10-01 ダウングレード Citigroup Neutral → Sell
2024-08-08 ダウングレード JP Morgan Overweight → Neutral
2024-08-08 ダウングレード Robert W. Baird Outperform → Neutral
2024-06-28 ダウングレード Argus Buy → Hold
2024-06-07 開始されました Mizuho Neutral
2024-06-06 開始されました Goldman Buy
2024-02-15 ダウングレード Guggenheim Buy → Neutral
2023-09-13 開始されました TD Cowen Market Perform
2023-07-10 ダウングレード Citigroup Buy → Neutral
2023-02-23 アップグレード Guggenheim Neutral → Buy
2023-01-12 ダウングレード Jefferies Buy → Hold
2022-09-30 アップグレード Jefferies Hold → Buy
2022-08-25 開始されました Credit Suisse Outperform
2022-08-04 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-05-24 開始されました Guggenheim Neutral
2022-04-25 ダウングレード Jefferies Buy → Hold
2022-04-07 開始されました Stephens Overweight
2022-02-17 繰り返されました BofA Securities Buy
2022-02-17 アップグレード Citigroup Neutral → Buy
2022-02-17 繰り返されました Deutsche Bank Buy
2022-02-17 繰り返されました Morgan Stanley Overweight
2022-02-17 繰り返されました UBS Buy
2021-08-05 再開されました Credit Suisse Neutral
2020-12-16 ダウングレード Citigroup Buy → Neutral
2020-09-10 アップグレード Jefferies Hold → Buy
2020-07-01 アップグレード BofA Securities Neutral → Buy
2020-05-13 アップグレード UBS Neutral → Buy
2020-04-21 ダウングレード Jefferies Buy → Hold
2020-03-27 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-03-02 開始されました Deutsche Bank Buy
2020-02-18 アップグレード Wolfe Research Peer Perform → Outperform
2020-01-10 アップグレード Goldman Neutral → Buy
2020-01-08 開始されました Wells Fargo Overweight
2020-01-07 開始されました Citigroup Buy
2019-10-18 ダウングレード BofA/Merrill Buy → Neutral
2019-06-10 開始されました SVB Leerink Outperform
2019-04-30 再開されました Evercore ISI Outperform
2018-12-14 開始されました Deutsche Bank Buy
2018-10-09 開始されました UBS Neutral
2018-08-23 アップグレード Raymond James Mkt Perform → Outperform
2018-07-17 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-06-15 アップグレード KeyBanc Capital Mkts Sector Weight → Overweight
2018-02-14 アップグレード SunTrust Hold → Buy
すべてを表示

Charles River Laboratories International Inc (CRL) 最新ニュース

pulisher
Apr 23, 2026

Charles River Laboratories International Inc (CRL) Shares Fall 9 - GuruFocus

Apr 23, 2026
pulisher
Apr 23, 2026

Charles River Laboratories International Drops 7.2% Amid Sector-Wide Selling - AlphaStreet

Apr 23, 2026
pulisher
Apr 23, 2026

Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Apr 23, 2026
pulisher
Apr 22, 2026

What you need to know ahead of Charles River Laboratories' earnings release - MSN

Apr 22, 2026
pulisher
Apr 22, 2026

Charles River gains new outperform at RBC despite NAMs related disruption - MSN

Apr 22, 2026
pulisher
Apr 22, 2026

Assessing Charles River Laboratories (CRL) Valuation After Recent Share Price Rebound - simplywall.st

Apr 22, 2026
pulisher
Apr 22, 2026

Assessing Charles River Laboratories (CRL) Valuation After Progress In Virtual Control Group Toxicology Studies - Yahoo Finance

Apr 22, 2026
pulisher
Apr 21, 2026

Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Apr 21, 2026
pulisher
Apr 21, 2026

Charles River Highlights Effectiveness of VCGs in Toxicology - PharmiWeb.com

Apr 21, 2026
pulisher
Apr 21, 2026

Charles River Laboratories Expected to Report Q1 2026 Earnings - HarianBasis.co

Apr 21, 2026
pulisher
Apr 19, 2026

Is Cheaper Energy and Shipping Altering The Investment Case For Charles River Laboratories (CRL)? - simplywall.st

Apr 19, 2026
pulisher
Apr 19, 2026

What You Need to Know Ahead of Charles River Laboratories' Earnings Release - Yahoo Finance

Apr 19, 2026
pulisher
Apr 19, 2026

Charles River Labs stock (US1598641074): Why Google Discover changes matter more now - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 18, 2026

Charles River (CRL) Stock: Should You Invest (Gains) 2026-04-18Community Exit Signals - UBND thành phố Hải Phòng

Apr 18, 2026
pulisher
Apr 18, 2026

Charles River Laboratories Experiences Evaluation Revision Amid Mixed Market Signals - Markets Mojo

Apr 18, 2026
pulisher
Apr 18, 2026

Charles River Laboratories International, Inc. $CRL Shares Purchased by Assetmark Inc. - MarketBeat

Apr 18, 2026
pulisher
Apr 17, 2026

A Look at Charles River Laboratories International Inc (CRL) Aft - GuruFocus

Apr 17, 2026
pulisher
Apr 17, 2026

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 17, 2026
pulisher
Apr 17, 2026

GPT-Rosalind Sparks CRO Sector Slump: Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact? - TradingKey

Apr 17, 2026
pulisher
Apr 17, 2026

Charles River Laboratories Schedules First-Quarter 2026 Earnings Release and Conference Call - BioSpace

Apr 17, 2026
pulisher
Apr 16, 2026

Charles River Laboratories International, Inc. (NYSE:CRL) Sees Large Increase in Short Interest - MarketBeat

Apr 16, 2026
pulisher
Apr 15, 2026

Why Charles River (CRL) Is Up 5.8% After Divesting Units And Refreshing Its Leadership Team - Yahoo Finance

Apr 15, 2026
pulisher
Apr 15, 2026

Charles River Laboratories International (NYSE:CRL) Stock Rating Upgraded by Royal Bank Of Canada - MarketBeat

Apr 15, 2026
pulisher
Apr 14, 2026

Charles River gains new Outperform at RBC despite NAMs related disruption - Seeking Alpha

Apr 14, 2026
pulisher
Apr 14, 2026

Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F - GlobeNewswire Inc.

Apr 14, 2026
pulisher
Apr 14, 2026

RBC Initiates Charles River Laboratories International at Outperform With $215 Price Target - marketscreener.com

Apr 14, 2026
pulisher
Apr 14, 2026

3 Stocks with Moat Rating Changes This Month - Morningstar

Apr 14, 2026
pulisher
Apr 13, 2026

RBC Capital initiates Charles River Labs stock at Outperform - Investing.com

Apr 13, 2026
pulisher
Apr 13, 2026

RBC Capital initiates Charles River Labs stock at Outperform By Investing.com - Investing.com South Africa

Apr 13, 2026
pulisher
Apr 13, 2026

Massachusetts Financial Services Co. MA Takes Position in Charles River Laboratories International, Inc. $CRL - MarketBeat

Apr 13, 2026
pulisher
Apr 11, 2026

Does Charles River’s NSG BioLabs Tie-Up Reshape the Bull Case For Charles River Laboratories (CRL)? - Sahm

Apr 11, 2026
pulisher
Apr 11, 2026

Charles River Laboratories Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Apr 11, 2026
pulisher
Apr 10, 2026

Q3 2025 Charles River Laboratories International Inc Earnings Call Transcript - GuruFocus

Apr 10, 2026
pulisher
Apr 10, 2026

Charles River Laboratories International (CRL) Positioned to Benefit from Preclinical Research Activity and Biotech Funding Recovery - insidermonkey.com

Apr 10, 2026
pulisher
Apr 10, 2026

Charles River, American Heart Association Partner to Advance Cardiovascular Health Awareness - Contract Pharma

Apr 10, 2026
pulisher
Apr 10, 2026

Charles River Labs stock: Margin Boost from Divestitures Signals Buy Opportunity - AD HOC NEWS

Apr 10, 2026
pulisher
Apr 09, 2026

Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Associa - PharmiWeb.com

Apr 09, 2026
pulisher
Apr 09, 2026

Charles River Advances Cardiovascular Health Awareness Through Support of the American Heart Association - The National Law Review

Apr 09, 2026
pulisher
Apr 09, 2026

Charles River Labs stock: New Asia partnership signals growth potential - AD HOC NEWS

Apr 09, 2026

Charles River Laboratories International Inc (CRL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
LH LH
$264.92
price down icon 2.82%
DGX DGX
$199.53
price down icon 2.19%
MTD MTD
$1,264.36
price down icon 3.49%
IQV IQV
$160.68
price down icon 8.29%
$201.14
price down icon 3.20%
WAT WAT
$311.20
price down icon 6.93%
大文字化:     |  ボリューム (24 時間):